julie gralow, md, reflects on the persephone trial from the 2018 asco annual meeting
Published 6 years ago • 229 plays • Length 2:27
Download video MP4
Download video MP3
Similar videos
-
0:32
julie gralow, md, on the implications of the persephone trial in early her2 breast cancer
-
0:52
julie gralow, md, tells us about the sandpiper proof of concept trial presented at acso 2018
-
0:44
julie gralow, md, regarding the reduction in cardiac events in the persephone study
-
2:35
julie gralow, md, elaborates on the issue of resistance to endocrine therapies
-
1:16
howard a. "skip" burris iii, md, facp, fasco, on the outcomes of the persephone clinical trial
-
15:12
carol greider, ph.d. - discovering telomerase and winning the nobel prize
-
27:14
worst drug for osteoporosis? bisphosphonate drugs, fear, confusion and facts
-
30:55
progesterone intolerance | dr louise newson
-
1:09
neelima denduluri, md, looks back on the short-her trial from the 2017 asco annual meeting
-
1:05
julie gralow, md, speaks to the significance of the monaleesa-3 study
-
2:01
julie gralow, md, on the kristine study
-
4:13
julie gralow, md, offers opinion on immunotherapy treatment trends in the management of tnbc
-
1:14
julie gralow, md, shares her thoughts on new drugs in development for breast cancer.
-
10:31
julie r. gralow, md: the atlas trial. tamoxifen for five years or ten years?
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
1:40
julie gralow, md, elaborates on how to differentiate cdk4/6 inhibitors
-
12:27
julie r. gralow, md: swog so226 trial and bisphosphonates update
-
1:15
dr. gralow discusses toxicities experienced in the swog s0307 trial
-
1:26
julie gralow, md, shares perspective on the evolving development immunotherapies in breast cancer
-
5:07
julie gralow, md, summarizes the rxponder trial from the 2020 san antonio breast cancer symposium
-
4:09
julie gralow, md, regarding the itomic trial data from the 2020 san antonio breast cancer symposium
Clip.africa.com - Privacy-policy